AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
59.70
+4.29 (7.74%)
At close: Mar 9, 2026, 4:00 PM EDT
60.58
+0.88 (1.47%)
After-hours: Mar 9, 2026, 7:34 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.72 billion as of March 9, 2026. Its market cap has increased by 198.90% in one year.
Market Cap
1.72B
Enterprise Value
1.65B
1-Year Change
198.90%
Ranking
Category
Stock Price
$59.70
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.72B, an increase of 455.97%. That is a compound annual growth rate of 20.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.59B | 18.67% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.64B |
| Innoviva | 1.63B |
| Novavax | 1.63B |
| Sionna Therapeutics | 1.62B |
| Agios Pharmaceuticals | 1.61B |
| Nanobiotix | 1.61B |
| Oruka Therapeutics | 1.60B |
| Oculis Holding AG | 1.59B |